Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: Comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole

Alimentary Pharmacology and Therapeutics

Volumn 20, Issue 1, 2004, Pages 117-122

  Levine, A ^a   Shevah, O ^a   Shabat Sehayek, V ^a   Aeed, H ^a   Boaz, M ^a   Moss, S F ^b   Niv, Y ^a   Avni, Y ^a   Shirin, H ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b RHODE ISLAND HOSPITAL   (United States)

^c WOLFSON MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIINFECTIVE AGENT; ANTIULCER AGENT; BENZIMIDAZOLE DERIVATIVE; DRUG DERIVATIVE; PROTON PUMP; SULFOXIDE; UREA;

ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIUM DETECTION; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; UREA BREATH TEST; BREATH ANALYSIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG ANTAGONISM; HELICOBACTER INFECTION; LABORATORY DIAGNOSIS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; BENZIMIDAZOLES; BREATH TESTS; FALSE NEGATIVE REACTIONS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMPS; SULFOXIDES; UREA;

EID: 3142736328     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02021.x     Document Type: Article

References (40)

1. Horn J. The proton pump inhibitors: similarities and differences. Clin Ther 2000; 22: 266-80.
2. Savarino V, Neri M, Vigneri S. PPI-triple therapy in the eradication of H. pylori infection. Gastroenterology 1999; 117: 746-7.
3. Stedman CAM, Barclay ML. Review article: comparison of pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther 2000; 14: 963-78.
4. Richardson P, Hawkey CJ, Stack WA. Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders. Drugs 1998; 56: 307-35.
5. Scott LJ, Dunn CJ, Mallarkey G, Sharpe M. Esomeprazole: a review of its use in the management of acid related disorders. Drugs 2002; 62: 1503-38.
6. Scholten T, Gatz G, Hole U. Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms. Aliment Pharmacol Ther 2003; 18: 587-94.
7. Chey W, Huang B, Jackson RL. Lansoprazole and esomeprazole in symptomatic GERD. Clin Drug invest 2003; 23: 69-84.
8. Laine L, Estrada R, Trujilo M, Kniggek K, Fennerty MB. Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med 1998; 129: 547-50.
9. 14C-urea breath test by a pH-dependent mechanism. Am J Gastroenterol 1997; 92: 446-50.
10. Greig MA, Neithercut WD, Hossack M et al. Suicidal destruction of H. pylori mediated by its urease activity. Gut 1990; 31: A600.
11. Eaton KA, Brooks CL, Morgan DR et al. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in Gnotobiotic piglets. Infec Immun 1991; 59: 2470-5.
12. Parente F, Sainaghi M, Sangaletti O, et al. Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the 13C-urea breath test. Aliment Pharmacol Ther 2002; 16: 553-7.
13. Dulbecco P, Gambaro C, Bilardi C, et al. Impact of long-term ranitidine and pantoprazole on accuracy of [13C] urea breath test. Dig Dis Sci 2003; 48: 315-21.
14. 13C-urea breath test. Am J Gastroenterol 2003; 98: 46-50.
15. Chey WD, Chathadi KV, Montague J, Ahmed F, Murthy U. Intragastric acidification reduces the occurrence of false-negative urea breath test results in patients taking a proton pump inhibitor. Am J Gastroenterol 2001; 96: 1028-32.
16. 13C-urea breath test. Am J Gastroenterol 1999; 94: 1214-17.
17. 13C-urea breath test: comparison of ranitidine with omeprazole. Aliment Pharmacol Ther 2000; 14: 291-7.
18. Savarino V, Tracci D, Dulbecco P et al. Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori. Am J Gastroenterol 2001; 96: 348-52.
19. 13C urea breath analyzer for Helicobacter pylori. Alimentary Pharmacol Ther 2001; 15: 389-94.
20. Rektorschek M, Weeks D, Sachs G, Melchers K. Influence of pH on metabolism and urease activity of Helicobacter pylori. Gastroenterology 1998; 115: 628-41.
21. Scott DR, Weeks D, Hong C, Postins S, Melchers K, Sachs G. The role of internal urease in acid resistance of Helicobacter pylori. Gastroenterology 1998; 114: 58-70.
22. 13C urea breath test (UBT) in the diagnosis of Helicobacter pylori: why does it work better with acid test meals? Gut 2003; 52: 933-7.
23. Meyer-Rosenberg K, Scott DR, Rex D, Melchers K, Sachs G. The effect of environmental pH on the proton motive force of Helicobacter pylori. Gastroenterology 1996; 111: 886-900.
24. Weeks DL, Eskandari S, Scott DR, Sachs G. A H+-Gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science 2000; 287: 482-5.
25. Bruley des Varannes S, Levy P, Lartigue S, Dellatolas F, Lemaire M, Galmiche JP. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. Aliment Pharmacol Ther 1994; 8: 309-14.
26. Florent C, Forestier S. 24 monitoring of intragastric acidity between lansoprazole 30 mg and pantoprazole 40 mg. Eur J Gastroenterol Hepatol 1997; 9: 195-200.
27. Huang JQ, Goldwater DR, Thompson ABR, et al. Acid suppression in healthy subjects following lansoprazole or pantoprazole. Aliment Pharmacol Ther 2002; 16: 425-33.
28. Andersson T, Rohss K, Bredberg E, Hassan-Alin M. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole. Aliment Pharmacol Ther 2001; 15: 1563-9.
29. Graham DY, Opekun AR, Hammoud F, et al. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol 2003; 98: 1005-9.
30. Sjostrom JE, Kuhler T, Larsson H. Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp. Antimicrob Agents Chemother 1997; 41: 1797-801.
31. Nagata K, Satoh H, Iwahi T, Shimoyama T, Tamura T. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: uniqe action selective for H. pylori cells. Antimicrob Agents Chemother 1993; 37: 769-74.
32. Nagata K, Takagi E, Tsuda M, et al. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease. Antimicrob Agents Chemother 1995; 3: 567-70.
33. Iwahi T, Satoh H, Nakao M, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991; 35: 490-6.
34. Nakao M, Malfertheiner P. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and lansoprazole against Helicobacter pylori. Helicobacter 1998; 3: 21-7.
35. Gatta L, Perna F, Figura N, et al. Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori. J Antimicrobial Chemother 2003; 51: 439-42.
36. 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut 1997; 40: 459-62.
37. Shiotani A, Saeed A, Yamaoka Y, Osato MS, Klein PD, Graham DY. Citric acid-enhanced Helicobacter pylori urease activity in vivo is unrelated to gastric emptying. Aliment Pharmacol Ther 2001; 15: 1763-7.
38. 14C-urea breath tests. Am J Gastroenterol 1996; 91: 89-92.
39. 13C-urea breath test in Helicobacter pylori-infected subjects. Aliment Pharmacol Ther 1999; 13: 1287-93.
40. Adachi K, Fujishiro H, Mihara T, Komazawa Y, Kinoshita Y. Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection. J Gastroenterol Hepatol 2003; 18: 168-71.